ACCC Committees and Liaisons

Douglas Flora, MD, LSSBB, FACCC, serves as the Executive Medical Director of Oncology Services at St. Elizabeth Cancer Center and is a key player in developing a nationally recognized lung cancer screening program at St. Elizabeth Healthcare. Dr. Flora was named the Robert and Dell Ann Sathe Endowed Chair in Oncology. He serves on the Board of Directors for the American Cancer Society, the Association of Community Cancer Centers, and the Kentucky Society of Clinical Oncology.

Dr. Flora has a history of measurable success in managing all operations, including project management, policy development, staff engagement, budget planning, research, public education, and patient service. He applies Lean Six Sigma methodologies to improve patient experience and staff productivity. He is the Physician Leader instrumental in the development/launch of the Center for Precision Medicine & Genomic Health.

He was born and raised in Cincinnati, Ohio, graduating from The Ohio State University College of Medicine in 1999. Dr. Flora has been named a Cincinnati Magazine “Top Doctor” in hematology and oncology for consecutive years since 2005.

David R. Penberthy, MD, MBA, is Medical Director, Radiation Oncology, of PennState Health Milson S. Hershey Medical Center. After completing his MBA from the Darden School of Business at the University of Virginia in 2011, Dr. Penberthy has served as the Medical Director of Radiation Oncology and Cancer Committee Chairman at Southside Regional Medical Center (SRMC) in Petersburg, Virginia. During his tenure as chairman, Dr. Penberthy led SRMC’s oncology program through two American College of Surgeons Commission on Cancer accreditation surveys resulting in cancer program accreditation, each time earning an Outstanding Achievement Award, an accolade achieved by only a small fraction of community oncology programs in the country.

After earning a Bachelor of Science degree in Electrical Engineering from Virginia Tech and a Doctor of Medicine degree from Virginia Commonwealth University, Dr. Penberthy completed a surgical internship at Bethesda Naval Hospital. He then served as a U.S. Navy Flight Surgeon with Fighter Squadron 101 in Oceana, Virginia. His strong interest and knowledge of technology eventually led him to the field of Radiation Oncology. In this field, Dr. Penberthy applies sophisticated medical technologies to alleviate the suffering caused by cancer, one of the most pressing medical issues of our generation.

Dr. Penberthy is enthusiastic about patient care and he is intensely engaged in providing state of the art, patient centered, compassionate oncology care.

Una Hopkins, DNP, MSN, BSN, FNP-BC, NE-BC, FACCC, RN, is a registered nurse with more than 30 years of experience in oncology, 25 as a nurse practitioner. Dr. Hopkins is currently the director for research and evidence-based practice at the Montefiore Medical Center in Bronx, New York, where she is responsible for the oversight and management of nurse engagement in programs of research and evidence-based practice, academic and affiliations, nursing internet and intranet development, and presentations and publications for the department of nursing. This includes the management of selected staff and operations, academic affiliations and funded educational projects, survey preparation, specialized training initiatives, education related to promotion of nursing research and evidence-based practice, oversight of project management, and funding attainment. 

Dr. Hopkins has received numerous awards for her accomplishments in clinical and research work and since 1927, has published over 20 articles in various medical journals. She holds bachelor’s and master’s degrees in Nursing Science from the College of New Rochelle where she also studied to become a family nurse practitioner. She received her doctorate from Pace University in New York City. Dr. Hopkins serves on the Advisory Committee for the ACCC Institute for Clinical Immuno-Oncology.

Leigha Senter, MS, LGC, FACCC, is a licensed genetic counselor and clinical professor at The Ohio State University’s James Cancer Hospital and Solove Research Institute where she specializes in cancer genetics risk assessment in women with gynecologic cancers. She is the Associate Director of the Division of Human Genetics.

Senter has more than 20 years of research experience in hereditary cancers with a primary focus in BRCA gene-related projects with more than 100 peer reviewed publications. She is currently a board member for the Association of Community Cancer Centers.

Senter earned a bachelor's degree in molecular genetics from The Ohio State University in Columbus, Ohio, and a master's degree in genetic counseling from the University of Pittsburgh in Pittsburgh, Pennsylvania

Wendi Waugh, BS, RT(R)(T), CMD, ODS, FACCC, is the administrative director of cancer services and ambulatory infusion at Southern Ohio Medical Center in Portsmouth, Ohio. She brings more than 30 years of experience in healthcare to this role. Waugh began her career in medical imaging but has spent the last 28 years in oncology. Her passion for community health and development led her to assume a larger leadership role at Southern Ohio Medical Center in 2013, when she assumed leadership of the community health and wellness teams.

A survivor of breast cancer, Waugh’s interests include community development, public speaking, leadership, dance, fitness, hiking and biking, and spending time with her family. She is a graduate of the Radiologic Technology Program at Shawnee State University and received her training for radiation therapy at Weber State University. Waugh received a Bachelor of Science in health administration and health informatics from Kennedy-Western Reserve, and she is also a certified cancer registrar and certified medical dosimetrist.

Douglas Flora, MD, LSSBB, FACCC, serves as the Executive Medical Director of Oncology Services at St. Elizabeth Cancer Center and is a key player in developing a nationally recognized lung cancer screening program at St. Elizabeth Healthcare. Dr. Flora was named the Robert and Dell Ann Sathe Endowed Chair in Oncology. He serves on the Board of Directors for the American Cancer Society, the Association of Community Cancer Centers, and the Kentucky Society of Clinical Oncology.

Dr. Flora has a history of measurable success in managing all operations, including project management, policy development, staff engagement, budget planning, research, public education, and patient service. He applies Lean Six Sigma methodologies to improve patient experience and staff productivity. He is the Physician Leader instrumental in the development/launch of the Center for Precision Medicine & Genomic Health.

He was born and raised in Cincinnati, Ohio, graduating from The Ohio State University College of Medicine in 1999. Dr. Flora has been named a Cincinnati Magazine “Top Doctor” in hematology and oncology for consecutive years since 2005.

Matthew Manning, MD, is chief of oncology at Cone Health Cancer Center in Greensboro, North Carolina. He is board certified in radiation oncology and clinical informatics, and his clinical interests include prostate, brain and spine, and thoracic cancers. His research has focused on high-tech therapies, including stereotactic radiosurgery and brachytherapy.

Dr. Manning has been published in the Journal of Applied Clinical Medical Physics and International Journal of Radiation Oncology | Biology | Physics. In 2016, his work received the Association of Community Cancer Centers’ Innovator Award. In collaboration with the Greensboro Health Disparities Collaborative, Dr. Manning has also co-authored studies to support eliminating racial disparities in cancer care.

Dr. Manning received his medical degree at Virginia Commonwealth University (VCU) School of Medicine and completed his residency at VCU Health System.

Douglas Flora, MD, LSSBB, FACCC, serves as the Executive Medical Director of Oncology Services at St. Elizabeth Cancer Center and is a key player in developing a nationally recognized lung cancer screening program at St. Elizabeth Healthcare. Dr. Flora was named the Robert and Dell Ann Sathe Endowed Chair in Oncology. He serves on the Board of Directors for the American Cancer Society, the Association of Community Cancer Centers, and the Kentucky Society of Clinical Oncology.

Dr. Flora has a history of measurable success in managing all operations, including project management, policy development, staff engagement, budget planning, research, public education, and patient service. He applies Lean Six Sigma methodologies to improve patient experience and staff productivity. He is the Physician Leader instrumental in the development/launch of the Center for Precision Medicine & Genomic Health.

He was born and raised in Cincinnati, Ohio, graduating from The Ohio State University College of Medicine in 1999. Dr. Flora has been named a Cincinnati Magazine “Top Doctor” in hematology and oncology for consecutive years since 2005.

Anne Marie Rainey, RN, MSN, CHC, is the Director of Quality and Value-Based Care at Clearview Cancer Institute in Huntsville, Alabama. She has previous experience in government quality reporting as a contractor for the Centers for Medicare & Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC).

After obtaining her Master of Nursing in Clinical Leadership and Administration, Rainey transitioned to the community oncology setting. Her work interests include quality metrics analysis, program implementation, health policy, and advocacy for community oncology.

Dr. Nadine J. Barrett is Senior Associate Dean for Community Engagement and Equity in Research at Wake Forest University School of Medicine and Atrium Health. Prior to that she held senior leadership roles as CTSI Co-Director for Equity and Stakeholder Strategy.

A medical sociologist by training, Dr. Barrett is a health disparities researcher, expert equity strategist, and a nationally-recognized leader in facilitating community/stakeholder and academic partnerships to advance health equity and developing training and methods to address implicit bias and structural and systemic racism that limits diverse participation in clinical and translational research and access to quality healthcare. Her goals are to integrate diverse stakeholder engagement in the research process and quality improvement in healthcare systems, enhance enrollment and retention of underrepresented groups in research through innovative interventions such JUST ASK, a nationally recognized program adapted by ACCC and ASCO, and diversify the healthcare workforce, and advance health equity.

Prior to her aforementioned role at Duke, Dr. Barrett was the founding director of the Duke Cancer Institute’s Office of Health Equity, where for eight years she led a team to create a nationally awarded community engagement model to advance health equity, through patient navigation, nationally funded pipeline training programs for underrepresented race and ethnic groups, and authentic community partnerships to inform and drive research and quality healthcare as advisors, experts, and participants. Her leadership in both nonprofit and academia spans local, national, and international partnerships to better serve and engage historically marginalized and underserved populations.